journal article·2023-07-11

Attenuating Uncontrolled Inflammation by Radical Trapping Chiral Polymer Micelles

Yao Li, Jie Wang, Yaru Li, Jiajia Luo, Fang Liu, Tiantian Chen, Yuting Ji, Hong Yang, Zheng Wang, Yanjun Zhao

ACS Nano· Volume 17· Issue 13
Publisher page

Abstract

As a clinical unmet need, uncontrolled inflammation is characterized by the crosstalk between oxidative stress and an inflammatory response. Ferroptotic cell death plays an essential role in uncontrolled inflammation. Hence ferroptosis inhibition is capable of managing hyper-inflammation, but the small molecular inhibitors show poor residence in cell membranes. The plasma membrane is the major site of lipid peroxidation that is the key event of ferroptosis. To address such a challenge, chiral radical trapping polymers were engineered by mimicking the structure of the cell membrane with imbedded helical proteins. The polymers were tailored to show an α-helix conformation that enabled increased hydrophobicity, prolonged membrane retention, and enhanced lipid radical trapping. The chiral polymers are amphiphilic, and the self-assembled micelles exhibited an extended blood circulation. At the lipopolysaccharide-induced macrophage and mice models, chiral polymer micelles effectively suppressed ferroptosis and repressed inflammatory cytokines. The current work provides an innovative means for attenuating uncontrolled inflammation by anti-ferroptotic polymer micelles.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Ferroptosis and cancer prognosis · Cholesterol and Lipid Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Pharmaceutical Science & Technology, Tianjin Key Laboratory for Modern Drug Delivery & High Efficiency, and Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin University, Tianjin 300072, China

The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Department of Pharmacology, School of Basic Medical Sciences, Intensive Care Unit, The Second Hospital, Tianjin Medical University, No. 22 Qixiangtai Road, Heping District, Tianjin 300070, China

Funding

National Natural Science Foundation of China

References (53)

Show source-provided references
1. 10.1158/0008-5472.CAN-14-096810.1158/0008-5472.CAN-14-0968 ↗
2. 10.1016/j.smim.2015.03.01310.1016/j.smim.2015.03.013 ↗
3. 10.1126/science.abb892510.1126/science.abb8925 ↗
4. 10.3390/ijms23191174010.3390/ijms231911740 ↗
5. 10.1146/annurev-med-042921-11283710.1146/annurev-med-042921-112837 ↗
6. 10.1515/hsz-2013-024110.1515/hsz-2013-0241 ↗
7. 10.1126/sciadv.aaz546610.1126/sciadv.aaz5466 ↗
8. 10.1016/j.pbiomolbio.2020.04.00110.1016/j.pbiomolbio.2020.04.001 ↗
9. 10.1007/s13346-021-00977-810.1007/s13346-021-00977-8 ↗
10. 10.1016/j.cell.2012.03.04210.1016/j.cell.2012.03.042 ↗
11. 10.1016/j.cell.2022.06.00310.1016/j.cell.2022.06.003 ↗
12. 10.3390/v1101007310.3390/v11010073 ↗
13. 10.3390/ijms2015368310.3390/ijms20153683 ↗
14. 10.1038/s41568-019-0149-110.1038/s41568-019-0149-1 ↗
15. 10.1038/s41565-022-01137-w10.1038/s41565-022-01137-w ↗
16. 10.1016/j.cmet.2020.10.01110.1016/j.cmet.2020.10.011 ↗
17. 10.1016/j.biopha.2022.11371110.1016/j.biopha.2022.113711 ↗
18. Langarizadeh M. A. · EXCLI J. · 2021 · 20 · 339
19. 10.1097/SHK.000000000000189310.1097/SHK.0000000000001893 ↗
20. 10.1038/s41571-020-00462-010.1038/s41571-020-00462-0 ↗
21. 10.1038/s41586-019-0945-510.1038/s41586-019-0945-5 ↗
22. 10.1038/s41580-020-00324-810.1038/s41580-020-00324-8 ↗
23. 10.1038/nchembio.223810.1038/nchembio.2238 ↗
24. 10.1146/annurev-cancerbio-030518-05584410.1146/annurev-cancerbio-030518-055844 ↗
25. 10.1016/j.cell.2017.11.04810.1016/j.cell.2017.11.048 ↗
26. 10.1038/s41586-019-1705-210.1038/s41586-019-1705-2 ↗
27. 10.1038/s41586-019-1707-010.1038/s41586-019-1707-0 ↗
28. 10.1021/acscentsci.9b0106310.1021/acscentsci.9b01063 ↗
29. 10.1038/s41586-021-03539-710.1038/s41586-021-03539-7 ↗
30. 10.1002/adfm.20211200010.1002/adfm.202112000 ↗
31. 10.1021/acsnano.0c0076410.1021/acsnano.0c00764 ↗
32. 10.1021/acs.biomac.7b0140910.1021/acs.biomac.7b01409 ↗
33. 10.1007/s11095-006-9132-010.1007/s11095-006-9132-0 ↗
34. 10.1073/pnas.71.5.181110.1073/pnas.71.5.1811 ↗
35. 10.1016/j.nantod.2012.01.00210.1016/j.nantod.2012.01.002 ↗
36. 10.1152/ajpcell.00462.201010.1152/ajpcell.00462.2010 ↗
37. 10.1073/pnas.171040811410.1073/pnas.1710408114 ↗
38. 10.1016/j.bbamem.2018.02.01010.1016/j.bbamem.2018.02.010 ↗
39. 10.1038/s41589-019-0408-110.1038/s41589-019-0408-1 ↗
40. 10.1016/0024-3205(94)00925-210.1016/0024-3205(94)00925-2 ↗
41. 10.1021/es061780010.1021/es0617800 ↗
42. 10.1517/14728222.7.1.3510.1517/14728222.7.1.35 ↗
43. 10.1046/j.1365-201X.2001.00891.x10.1046/j.1365-201X.2001.00891.x ↗
44. 10.1016/j.freeradbiomed.2021.07.01910.1016/j.freeradbiomed.2021.07.019 ↗
45. 10.1016/j.bbagen.2020.12963110.1016/j.bbagen.2020.129631 ↗
46. 10.1016/j.abb.2023.10953510.1016/j.abb.2023.109535 ↗
47. 10.1021/acs.nanolett.9b0049610.1021/acs.nanolett.9b00496 ↗
48. 10.1021/acsmacrolett.0c0000410.1021/acsmacrolett.0c00004 ↗
49. 10.1038/nbt.333010.1038/nbt.3330 ↗
50. 10.4049/jimmunol.180.9.577110.4049/jimmunol.180.9.5771 ↗
51. 10.1021/acs.jmedchem.5b0164110.1021/acs.jmedchem.5b01641 ↗
52. 10.1016/j.biomaterials.2019.11948610.1016/j.biomaterials.2019.119486 ↗
53. 10.1007/s11095-012-0848-810.1007/s11095-012-0848-8 ↗